Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
59.95%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 41.63Close
$ 28.23 - $ 45.74 52-Week Range
Ticker Information
Ticker
XENECompany Name
XENON PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXENON PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XENE - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.5M | 59.95% | $ 7.5M |
| 3/31/2025 | $ 4.2M | 55.95% | $ 7.5M |
| 12/31/2024 | $ 3.81M | 0% | $ 0 |
| 9/30/2024 | $ 2.78M | 0% | $ 0 |
| 6/30/2024 | $ 3.84M | 0% | $ 0 |
| 3/31/2024 | $ 3.79M | 0% | $ 0 |
| 12/31/2023 | $ 3.54M | 0% | $ 0 |
| 9/30/2023 | $ 3.21M | 0% | $ 0 |
| 6/30/2023 | $ 1.83M | 1385.61% | $ 132K |
| 3/31/2023 | $ 1.6M | 239.82% | $ 668K |
Key Performance Insights, Last 5 Years
- XENON PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 1.94%.
- Over the past 5 years, XENON PHARMACEUTICALS INC's average DepAmor % has been 128.54%.
- The median DepAmor % for XENON PHARMACEUTICALS INC during this period was 5.36%
- XENON PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 1385.61%.
- The lowest DepAmor % recorded by XENON PHARMACEUTICALS INC in the same timeframe 1.94%
XENON PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for XENON PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 588K ] / Revenues [ $ 30.34M ]
(=) DepAmor % [ 1.94% ] XENE - Depreciation and Amortization Margin, Last 5 years
1.94%
Minimum
Sep 30, 2020
1385.61%
Maximum
Jun 30, 2023
128.54%
Average
5.36%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |